Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DIASORIN MOLECULAR, LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-12-01 to 2025-09-30
Current total value of award: $260564
Description: DECREASE QUANTITY ON CLIN 3001 AND 3009